Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
6,449,500
-
Shares change
-
+1,188,405
-
Total reported value, excl. options
-
$259,443,359
-
Value change
-
+$46,323,699
-
Number of buys
-
22
-
Number of sells
-
-37
-
Price
-
$40.24
Significant Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q1 2016
85 filings reported holding XPH - SPDR SERIES TRUST - S&P PHARMAC as of Q1 2016.
SPDR SERIES TRUST - S&P PHARMAC (XPH) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,449,500 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (2,576,497 shares), BARCLAYS PLC (650,000 shares), MORGAN STANLEY (487,760 shares), UBS Group AG (464,838 shares), Psagot Investment House Ltd. (425,898 shares), BANK OF AMERICA CORP /DE/ (394,847 shares), Wharton Business Group, LLC (260,540 shares), Baird Financial Group, Inc. (122,015 shares), Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD (107,450 shares), and SG Americas Securities, LLC (102,078 shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.